Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: Setting an evidence-based benchmark for the best-quality cancer care

European Journal of Cancer

Volumn 45, Issue 12, 2009, Pages 2150-2159

  Ng, Weng ^a   Jacob, Susannah ^a   Delaney, Geoff ^a   Barton, Michael ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Chemotherapy; Evidence based; Guidelines; Head and neck cancer; Quality; Utilisation

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; EVIDENCE BASED PRACTICE; HEAD AND NECK CARCINOMA; HEALTH CARE QUALITY; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LIP CARCINOMA; MONTE CARLO METHOD; MOUTH CARCINOMA; NASOPHARYNX CARCINOMA; NOSE CAVITY CANCER; OROPHARYNX CARCINOMA; PARANASAL SINUS CARCINOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; SALIVARY GLAND CARCINOMA; SENSITIVITY ANALYSIS; TREATMENT INDICATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENCHMARKING; CARCINOMA, SQUAMOUS CELL; EVIDENCE-BASED MEDICINE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC;

EID: 67651124867     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.02.007     Document Type: Article

References (56)

1. Hoffman H.T., Karnell L.H., and Funk G.F. The national cancer data base report on cancer of the head and neck. Arch Otolaryngol - Head Neck Surg 124 (1998) 951-962
2. Northern and Yorkshire Cancer Registry and Information Service (NYCRIS). Northern and Yorkshire Cancer Networks. Head and neck factsheet - incidence, mortality, treatment and survival in Northern and Yorkshire 2003. Available from: [accessed 10.10.07].
3. Delaney G., Jacob S., and Barton M. Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma. Cancer 103 (2005) 2216-2227
4. Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Institute, DCCPS, Surveillance Research Program. SEER*RX antineoplastic drug database (version 1.1.1). Available from: [release 01.01.06].
5. National Comprehensive Cancer Network. Clinical practice guidelines in oncology - v.1.2007 - head and neck cancers. Available from: http://www.nccn.org [accessed 10.09.07].
6. National Cancer Institute. PDQ cancer information summaries: treatment of lip and oral cavity cancer. Available from: [accessed 10.09.07].
7. National Cancer Institute. PDQ cancer information summaries: treatment of laryngeal cancer. Available from: [accessed 10.09.07].
8. National Cancer Institute. PDQ cancer information summaries: treatment of oropharyngeal cancer. Available from: [accessed 10.09.07].
9. National Cancer Institute. PDQ cancer information summaries: treatment of nasopharyngeal cancer. Available from: [accessed 10.09.07].
10. National Cancer Institute. PDQ cancer information summaries: treatment of paranasal sinus and nasal cavity cancer. Available from: [accessed 10.09.07].
11. National Cancer Institute. PDQ cancer information summaries: treatment of salivary gland cancer. Available from: [accessed 10.09.07].
12. National Cancer Institute. PDQ cancer information summaries: treatment of hypopharyngeal cancer. Available from: [accessed 10.09.07].
13. BC Cancer Agency. Cancer management guidelines: cancer of the oral cavity. Available from: [accessed 10.09.07].
14. BC Cancer Agency. Cancer management guidelines: cancer of the lip. Available from: [accessed 10.09.07].
15. BC Cancer Agency. Cancer management guidelines: carcinoma of the oropharynx. Available from: [accessed 10.09.07].
16. BC Cancer Agency. Cancer management guidelines: carcinoma of the hypopharynx. Available from: [accessed 10.09.07].
17. BC Cancer Agency. Cancer management guidelines: carcinoma of the nasopharynx. Available from: [accessed 10.09.07].
18. BC Cancer Agency. Cancer management guidelines: cancer of the larynx. Available from: [accessed 10.09.07].
19. BC Cancer Agency. Cancer management guidelines: cancer of the salivary glands. Available from: [accessed 10.09.07].
20. BC Cancer Agency. Cancer management guidelines: cancer of the nasal cavity and paranasal sinuses. Available from: [accessed 10.09.07].
21. Cancer Care Ontario Practice Guideline Initiative. Chemotherapy with radiotherapy for nasopharyngeal cancer: a clinical practice guideline (evidence-based series #5-7). Available from: [accessed 10.09.07].
22. Cancer Care Ontario Practice Guideline Initiative. Concomitant chemotherapy and radiotherapy in squamous cell head and neck cancer (excluding nasopharynx). Available from: [accessed 10.09.07].
23. Cancer Care Ontario Practice Guideline Initiative. The role of postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a clinical practice guideline (evidence-based series #5-10). Available from: [accessed 10.09.07].
24. Cancer Care Ontario Practice Guideline Initiative. The role of neoadjuvant chemotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck (excluding nasopharynx). Available from: [accessed 10.09.07].
25. Scottish Intercollegiate Guidelines Network. Diagnosis and management of head and neck cancer. A national clinical guideline. Available from: [accessed 12.09.07].
26. National Health and Medical Research Council. Guide to the development, implementation and evaluation of clinical practice guidelines, appendix B, vol. 56. Canberra: National Health and Medical Research Council; 1998.
27. Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR). Cancer in Australia 2003. Cancer series no. 37. Canberra: Australian Institute of Health and Welfare; 2007.
28. SA Cancer Registry. Epidemiology of cancer in South Australia. September 2000 (cancer series no. 22). Adelaide: South Australian Cancer Registry; 2000.
29. Commission on Cancer, American College of Surgeons. NCDB benchmark reports, v1.1. Site by stage distribution of cases reported to the NCDB: diagnosis year 2004. Available from: [accessed 10.10.07].
30. Delaney G., Jacob S., Featherstone C., and Barton M.B. The role of radiotherapy in cancer treatment. Estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104 (2005) 1129-1137
31. Buccheri G., Ferrigno D., and Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A (1996) 1135-1141
32. Centre for Epidemiology and Research. 2005 report on adult health from the New South Wales population health survey. Sydney: NSW Department of Health; 2006.
33. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
34. Piccirillo J.F. Importance of comorbidity in head and neck cancer. Laryngoscope 110 (2000) 593-602
35. Piccirillo J.F., and Vlahiotis A. Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis. Curr Oncol Rep 8 (2006) 123-129
36. Bremnes R.M., Andersen K., and Wist E.A. Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy. Eur J Cancer 31A (1995) 1955-1959
37. Duric V.M., Stockler M.R., Heritier S., et al. Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now. Ann Oncol 16 (2005) 1786-1794
38. Coeburg J.W.W., Jannsen-Heijnen, Post P.N., and Razenberg P.P.A. Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996. J Clin Epidemiol 52 (1999) 1131-1136
39. Winquist E., Oliver T., and Gilbert R. Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis. Head Neck 29 (2007) 38-46
40. Baujat B., Audry H., Bourhis J., et al. Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. Cochrane Database Syst Rev 18 4 (2006) CD004329
41. Vahtsevanos K., Ntomouchtsis A., Andreadis C., et al. Distant bone metastases from carcinoma of the lip: a report of four cases. Int J Oral Maxillofacial Surg 36 (2007) 180-185
42. Zitsch R.P., Park C.W., Renner G.J., and Rea J.L. Outcome analysis for lip carcinoma. Otolaryngol Head Neck Surg 113 (1995) 589-596
43. Rowe D.E., Carroll R.J., and Day C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear and lip. Implications for treatment modality selection. J Am Acad Dermatol 26 (1992) 976-990
44. Carvalho A.L., Magrin J., and Kowalski L.P. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Dis 9 (2003) 112-118
45. Koo B.S., Lim Y.C., Lee J.S., and Choi E.C. Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity. Oral Oncol 42 (2006) 789-794
46. Lee A.W.M., Sze W.M., Au J.S.K., et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61 (2005) 1107-1116
47. Chua D.T., Sham J.S., Kwong D.L., and Au G.K. Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma. Cancer 98 (2003) 74-80
48. Corry J., Fisher R., Rischin D., et al. Clinical verification of the superiority of the current International Union Against Cancer staging criteria in an Australian population of patients with nasopharyngeal carcinoma. Australas Radiol 48 (2004) 509-515
49. Yu K.H., Leung S.F., Tung S.Y., et al. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck 27 (2005) 397-405
50. Selek U., Garden A.S., Morrison W.H., et al. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Bio Phys 59 (2004) 743-751
51. Hoffman H.T., Karnell L.H., Shah J.P., et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope 107 (1997) 1005-1017
52. Nakamura K., Shioyama Y., Kawashima M., et al. Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 65 (2006) 1045-1050
53. Johansen L.V., Grau C., and Overgaard J. Glottic carcinoma - patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol 63 (2002) 257-267
54. Ries L.A.G., Melbert D., Krapcho M., et al. SEER cancer statistics review, 1975-2004 (2007), National Cancer Institute
55. Dulguerov P., Jacobsen M.S., Allal A.S., et al. Nasal and paranasal sinus carcinoma: are we making progress?. Cancer 92 (2001) 3012-3029
56. Terhaard C.H.J., Lubsen H., Van der Tweel I., et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch Head and Neck Oncology Cooperative Group. Head Neck 26 (2004) 681-693